Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Journal of Medical Genetics|December 20, 2023
Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400Emma R Woodward, Fiona Lalloo, Claire Forde, et al.European Journal of Cancer (Oxford, England : 1990)|July 23, 2020
BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort studySarah J Kitson, Cemsel Bafligil, Neil A J Ryan, et al.Journal of Medical Genetics|September 12, 2020
Constitutional de novo deletion CNV encompassing REST predisposes to diffuse hyperplastic perilobar nephroblastomatosis (HPLN)Zerin Hyder, Adele Fairclough, Mike Groom, et al.JAMA Oncology|December 15, 2015
Multilocus Inherited Neoplasia Alleles Syndrome: A Case Series and ReviewJames Whitworth, Anne-Bine Skytte, Lone Sunde, et al.Breast (Edinburgh, Scotland)|August 31, 2021
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancerD Gareth Evans, Ashu Gandhi, Julie Wisely, et al.Journal of Medical Genetics|September 12, 2020
Assessment of mismatch repair deficiency in ovarian cancerEmma J Crosbie, Neil A J Ryan, Rhona J McVey, et al.Cancers|January 11, 2024
Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian CancerRobert D Morgan, George J Burghel, Helene Schlecht, et al.Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.Genes|September 28, 2021
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau DiseaseHugh Furness, Louay Salfity, Johanna Devereux, et al.International Journal of Cancer|November 5, 2020
Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levelsEmma J Crosbie, Nicola Flaum, Elaine F Harkness, et al.Pageof 9